Northern Biologics
Northern Biologics’ mission is to develop first-in-class antibody therapeutics for oncology
Secteur: Life Sciences
Repare Therapeutics
Clinical stage company developing therapeutics targeting DNA repair proteins for the treatment of cancer
Turnstone Biologics
Turnstone Biologics’ mission is to deliver breakthrough viral immunotherapies to improve survival for patients with cancer
Clarus Ventures
American biotherapeutics-focused fund with a barbell investment strategy between early stage disruptive platforms and Phase III defined exit deals
Genesys Capital
Toronto & Montreal based early stage life sciences fund focused on building companies in the high-growth sectors of healthcare and biotechnology
Lumira Ventures
Growth equity fund investing in biotechnology and medical device companies
Persistence Capital Partners
Healthcare-focused fund dedicated to buyout and growth opportunities across Canada in healthcare services and technologies
Sofinnova Partners
Pan-European fund creating and building entrepreneur-driven companies in biotechnology and medical devices
Versant Ventures
Californian venture firm operating incubators in Canada and investing through self-sustaining drug development units
Zymeworks
Zymeworks is a biotherapeutics company that is developing best-in-class Azymetric bi-specific antibodies and antibody drug conjugates for the treatment of cancer, autoimmune and inflammatory diseases